Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients

Arthritis and Rheumatism
Robert W HoffmanG C Sharp


Serum samples from patients with connective tissue disease (CTD) were characterized using a recently developed enzyme-linked immunosorbent assay for reactivity with individual specific polypeptides of U1 small nuclear ribonucleoproteins, including the U1-70-kd protein. The distribution of HLA antigens was compared in CTD patients with and in those without anti-U1-70-kd autoantibodies and in normal controls. The frequencies of HLA-DR4 and HLA-DRw53 were increased among the anti-U1-70-kd autoantibody positive CTD group compared with the frequencies in anti-U1-70-kd autoantibody negative systemic lupus erythematosus patients and compared with normal controls. We conclude that the presence of autoantibodies reactive with the anti-U1-70-kd protein antigen is associated with HLA-DR4 and HLA-DRw53.


Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M R Lerner, J A Steitz
Aug 1, 1989·Journal of Autoimmunity·F Tron, J F Bach
Jun 1, 1989·Journal of Autoimmunity·P LymberiS Avrameas
Jan 1, 1988·Arthritis and Rheumatism·C M BlackR S Pereira
Sep 1, 1986·Arthritis and Rheumatism·R W HoffmanD N Glass
Jan 1, 1985·Scandinavian Journal of Rheumatology. Supplement·W J van Venrooij, W J Habets
Jan 1, 1985·Springer Seminars in Immunopathology·E N Harris, G R Hughes
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester

❮ Previous
Next ❯


May 20, 1998·Arthritis and Rheumatism·J S Smolen, G Steiner
Nov 18, 1997·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·Y Farhey, E V Hess
Jan 1, 1996·Rheumatology International·A GhirardelloP F Gambari
Mar 1, 1994·Immunology Today·M T Dorak, A K Burnett
Jun 30, 1994·The New England Journal of Medicine·J A Mills
Feb 16, 2008·Journal of Autoimmune Diseases·Masha Fridkis-Hareli
Mar 26, 2011·Rheumatology International·Elisa Watanabe CamargoJozélio Freire de Carvalho
Mar 12, 2005·Current Rheumatology Reports·Carol A Feghali-Bostwick
Jan 1, 1993·Scandinavian Journal of Rheumatology·R HämeenkorpiM Hakala
Feb 7, 1998·Annals of Medicine·H Michels
Oct 1, 2011·Seminars in Arthritis and Rheumatism·Susanna CappelliMarco Matucci Cerinic
Dec 11, 2007·Best Practice & Research. Clinical Rheumatology·Martin Aringer, Josef S Smolen
Apr 29, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Robert W Hoffman, Marcos E Maldonado
Apr 1, 1995·Seminars in Arthritis and Rheumatism·C A von Mühlen, E M Tan
Aug 9, 2005·Rheumatic Diseases Clinics of North America·Eric L Greidinger, Robert W Hoffman
Jul 6, 2000·Baillière's Best Practice & Research. Clinical Rheumatology·P J Maddison
Apr 1, 1994·Clinics in Dermatology·D Alarcón-Segovia
Jul 26, 2002·Lupus·G C Sharp
Feb 3, 2006·Arthritis and Rheumatism·Eric L GreidingerRobert W Hoffman
Mar 5, 2020·Clinical and Experimental Medicine·Marta R Alves, David A Isenberg
Jun 22, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B L TalkenR W Hoffman
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eric L GreidingerRobert W Hoffman
Mar 29, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·YunJuan ZangEric L Greidinger
Sep 1, 1995·Clinical and Experimental Immunology·S FenningM Schlesier
Sep 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eric L GreidingerRobert W Hoffman

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.